Showing 1 - 1 of 1
AFP, Published on 17/12/2019
» ZURICH - Swiss pharmaceuticals giant Roche said it had received the necessary approval from competition authorities to acquire US gene-therapy group Spark, after the two companies reached a multibillion-dollar deal earlier this year.